Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

por Cocco, Stefania, Piezzo, Michela, Calabrese, Alessandra, Cianniello, Daniela, Caputo, Roberta, Di Lauro, Vincenzo, Fusco, Giuseppina, di Gioia, Germira, Licenziato, Marina, de Laurentiis, Michelino
Publicado 2020

Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies

por Berretta, Massimiliano, Quagliariello, Vincenzo, Maurea, Nicola, Di Francia, Raffaele, Sharifi, Saman, Facchini, Gaetano, Rinaldi, Luca, Piezzo, Michela, Manuela, Ceccarelli, Nunnari, Giuseppe, Montopoli, Monica
Publicado 2020

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

por Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Publicado 2017

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors

por Piezzo, Michela, Cocco, Stefania, Caputo, Roberta, Cianniello, Daniela, Gioia, Germira Di, Lauro, Vincenzo Di, Fusco, Giuseppina, Martinelli, Claudia, Nuzzo, Francesco, Pensabene, Matilde, Laurentiis, Michelino De
Publicado 2020

Targeting Autophagy in Breast Cancer

por Cocco, Stefania, Leone, Alessandra, Piezzo, Michela, Caputo, Roberta, Di Lauro, Vincenzo, Di Rella, Francesca, Fusco, Giuseppina, Capozzi, Monica, Gioia, Germira di, Budillon, Alfredo, De Laurentiis, Michelino
Publicado 2020

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

por Maraolo, Alberto Enrico, Crispo, Anna, Piezzo, Michela, Di Gennaro, Piergiacomo, Vitale, Maria Grazia, Mallardo, Domenico, Ametrano, Luigi, Celentano, Egidio, Cuomo, Arturo, Ascierto, Paolo A., Cascella, Marco
Publicado 2021

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast ca...

por Cocco, Stefania, Leone, Alessandra, Roca, Maria Serena, Lombardi, Rita, Piezzo, Michela, Caputo, Roberta, Ciardiello, Chiara, Costantini, Susan, Bruzzese, Francesca, Sisalli, Maria José, Budillon, Alfredo, De Laurentiis, Michelino
Publicado 2022

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patient...

por Cozzolino, Mauro, Cocco, Stefania, Piezzo, Michela, Celia, Giovanna, Costantini, Susan, Abate, Valentina, Capone, Francesca, Barberio, Daniela, Girelli, Laura, Cavicchiolo, Elisa, Ascierto, Paolo Antonio, Madonna, Gabriele, Budillon, Alfredo, De Laurentiis, Michelino
Publicado 2021

Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

por Piezzo, Michela, Chiodini, Paolo, Riemma, Maria, Cocco, Stefania, Caputo, Roberta, Cianniello, Daniela, Di Gioia, Germira, Di Lauro, Vincenzo, Rella, Francesca Di, Fusco, Giuseppina, Iodice, Giovanni, Nuzzo, Francesco, Pacilio, Carmen, Pensabene, Matilde, Laurentiis, Michelino De
Publicado 2020

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

por Piezzo, Michela, D’Aniello, Roberta, Avallone, Ilaria, Barba, Bruno, Cianniello, Daniela, Cocco, Stefania, D’Avino, Antonio, Di Gioia, Germira, Di Lauro, Vincenzo, Fusco, Giuseppina, Piscitelli, Raffaele, von Arx, Claudia, De Laurentiis, Michelino, Maiolino, Piera
Publicado 2021

Clinical trials and drug cost savings for Italian health service

por D’Ambrosio, Francesca, De Feo, Gianfranco, Botti, Gerardo, Capasso, Arturo, Pignata, Sandro, Maiolino, Piera, Triassi, Maria, Nardone, Antonio, Perrone, Franco, Piezzo, Michela, Grimaldi, Antonio Maria, Palazzo, Ida, De Stasio, Immacolata, D’Aniello, Roberta, Morabito, Alessandro, Pascarella, Giacomo
Publicado 2020

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

por Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Michela, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri, Valter
Publicado 2018